Polyethylene Glycols

erythropoietin ; Homo sapiens







25 Article(s)
Download
PMID
Title
Pub. Year
#Total Relationships
1 34891120 Impact of anti-PEG antibody affinity on accelerated blood clearance of pegylated epoetin beta in mice. 2022 Feb 7
2 34905300 Introduction of a PEGylated EPO conjugate as internal standard for EPO analysis in doping controls. 2021 Dec 14 2
3 31770451 Model-based approach for methoxy polyethylene glycol-epoetin beta drug development in paediatric patients with anaemia of chronic kidney disease. 2020 Apr 1
4 30426415 SARCOSYL-PAGE: Optimized Protocols for the Separation and Immunological Detection of PEGylated Proteins. 2019 1
5 28168382 Molecular Design, Expression and Evaluation of PASylated Human Recombinant Erythropoietin with Enhanced Functional Properties. 2017 Feb 1
6 26776361 Stabilization of bacterially expressed erythropoietin by single site-specific introduction of short branched PEG chains at naturally occurring glycosylation sites. 2016 May 24 4
7 24847351 Regulation of Hepcidin-25 by Short- and Long-Acting rhEPO May Be Dependent on Ferritin and Predict the Response to rhEPO in Hemodialysis Patients. 2014 Jan 3
8 25367412 Preservation of anemia control and weekly ESA dosage after conversion from PEG-Epoetin beta to darbepoetin alfa in adult hemodialysis patients: the TRANSFORM study. 2014 Nov 3
9 23293515 Improvement of in vivo efficacy of recombinant human erythropoietin by encapsulation in PEG-PLA micelle. 2013 1
10 23318685 Peginesatide clearance, distribution, metabolism, and excretion in monkeys following intravenous administration. 2013 Apr 2
11 24173670 Dose conversion ratio in hemodialysis patients switched from darbepoetin alfa to PEG-epoetin beta: AFFIRM study. 2013 Nov 1
12 22421952 Use of methoxy polyethylene glycol-epoetin beta in stage 3, 4 or 5 non-dialysis chronic kidney disease. 2012 5
13 22536082 Methoxy polyethylene glycol-epoetin beta for anemia with chronic kidney disease. 2012 3
14 22585478 SARCOSYL-PAGE: a new electrophoretic method for the separation and immunological detection of PEGylated proteins. 2012 1
15 22987365 The impact of sialic acids on the pharmacokinetics of a PEGylated erythropoietin. 2012 Dec 2
16 21254454 Screen and confirmation of PEG-epoetin β in equine plasma. 2011 Jan 1
17 21753873 Design, modeling, expression, and chemoselective PEGylation of a new nanosize cysteine analog of erythropoietin. 2011 1
18 19761439 Genotoxicity studies on HM10760A, recombinant human erythropoietin conjugated to globin fragment. 2010 Apr 1
19 20427020 PEGylation markedly enhances the in vivo potency of recombinant human non-glycosylated erythropoietin: a comparison with glycosylated erythropoietin. 2010 Aug 3 1
20 19676084 CE immunoassay with enhanced chemiluminescence detection of erythropoietin using silica dioxide nanoparticles as pseudostationary phase. 2009 Sep 1
21 18922615 Erythropoietins: a common mechanism of action. 2008 Dec 1
22 17032916 New agents that stimulate erythropoiesis. 2007 Feb 1 1
23 15784336 Mixed-effects modelling of the interspecies pharmacokinetic scaling of pegylated human erythropoietin. 2005 Apr 1
24 10089903 Expansion of granulocyte colony-stimulating factor/chemotherapy-mobilized CD34+ hematopoietic progenitors: role of granulocyte-macrophage colony-stimulating factor/erythropoietin hybrid protein (MEN11303) and interleukin-15. 1999 Mar 1
25 9427659 Amino-terminal dimerization of an erythropoietin mimetic peptide results in increased erythropoietic activity. 1997 Dec 4